Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2016 (2016), Article ID 4754031, 13 pages
http://dx.doi.org/10.1155/2016/4754031
Review Article

Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion

Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA

Received 16 December 2015; Revised 25 February 2016; Accepted 2 March 2016

Academic Editor: Hendrik Van Poppel

Copyright © 2016 M. Sean Peach et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sriprasad, M. R. Feneley, and P. M. Thompson, “History of prostate cancer treatment,” Surgical Oncology, vol. 18, no. 3, pp. 185–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. N. Aronowitz, “Whitmore, Henschke, and Hilaris: the reorientation of prostate brachytherapy (1970–1987),” Brachytherapy, vol. 11, no. 2, pp. 157–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. H. Holm, “Interventional ultrasound in Europe,” Ultrasound in Medicine & Biology, vol. 24, no. 6, pp. 779–791, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Ragde, G. L. Grado, B. Nadir, and A.-A. Elgamal, “Modern prostate brachytherapy,” CA: A Cancer Journal for Clinicians, vol. 50, no. 6, pp. 380–393, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. National Comprehensive Cancer Network, Prostate Cancer (Version 1.2015), 2015.
  6. J. Hugosson, S. Carlsson, G. Aus et al., “Mortality results from the Göteborg randomised population-based prostate-cancer screening trial,” The Lancet Oncology, vol. 11, no. 8, pp. 725–732, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Libby, “Implementation of image-guided prostate HDR brachytherapy using MR-ultrasound fusion,” in Proceedings of the 57th Annual Meeting of the AAPM, Anaheim, Calif, USA, July 2015, Medical Physics, vol. 42, no. 6, p. 3572, 2015.
  8. B. Libby, “Real time ultrasound guidance for optimizing high dose rate prostate brachytherapy,” in Proceedings of the 55th Annual Meeting of the AAPM, Medical Physics 40:6, Invited oral presentation, Indianapolis, Ind, USA, August 2013.
  9. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Journal of Clinical Epidemiology, vol. 62, no. 10, pp. 1006–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Al-Qaisieh, J. Mason, P. Bownes et al., “Dosimetry modeling for focal low-dose-rate prostate brachytherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 92, no. 4, pp. 787–793, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Mason, B. Al-Qaisieh, P. Bownes et al., “Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility study,” Brachytherapy, vol. 13, no. 2, pp. 137–145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Mason, B. Al-Qaisieh, P. Bownes, D. Thwaites, and A. Henry, “Dosimetry modeling for focal high-dose-rate prostate brachytherapy,” Brachytherapy, vol. 13, no. 6, pp. 611–617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Mason, P. Bownes, B. Carey, and A. Henry, “Comparison of focal boost high dose rate prostate brachytherapy optimisation methods,” Radiotherapy and Oncology, vol. 117, no. 3, pp. 521–524, 2015. View at Publisher · View at Google Scholar
  14. M. Kamrava, M. P. Chung, O. Kayode et al., “Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment,” Brachytherapy, vol. 12, no. 5, pp. 434–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Banerjee, S.-J. Park, E. Anderson, D. J. Demanes, J. Wang, and M. Kamrava, “From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: a dosimetric analysis,” Brachytherapy, vol. 14, no. 3, pp. 366–372, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Peters, M. Maenhout, J. R. N. van der Voort Van Zyp et al., “Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life,” Radiotherapy and Oncology, vol. 112, no. 1, pp. 77–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Moman, C. A. T. van den Berg, A. E. Boeken Kruger et al., “Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, pp. 741–746, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Todor, I. J. Barani, P.-S. Lin, and M. S. Anscher, “Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 1, pp. 297–304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. L. Polders, M. van Herk, K. Nichol et al., “Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer,” Acta Oncologica, vol. 54, no. 6, pp. 839–846, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. J. DiBiase, K. Hosseinzadeh, R. P. Gullapalli et al., “Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 52, no. 2, pp. 429–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. R. D. Ennis, S. A. Quinn, F. Trichter et al., “Phase I/II prospective trial of cancer-specific imaging using ultrasound spectrum analysis tissue-type imaging to guide dose-painting prostate brachytherapy,” Brachytherapy, vol. 14, no. 6, pp. 801–808, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. C. C. Hsu, H. Hsu, B. Pickett et al., “Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 85, no. 2, pp. 370–377, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Barret, Y. Ahallal, R. Sanchez-Salas et al., “Morbidity of focal therapy in the treatment of localized prostate cancer,” European Urology, vol. 63, no. 4, pp. 618–622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Wallace, I. Avital, A. Stojadinovic, B. Brucher, E. Coté, and J. Yu, “Multi-parametric mri-directed focal salvage permanent interstitial brachytherapy for locally recurrent adenocarcinoma of the prostate: a novel approach,” Journal of Cancer, vol. 4, no. 2, pp. 146–151, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Salembier, P. Lavagnini, P. Nickers et al., “Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy,” Radiotherapy and Oncology, vol. 83, no. 1, pp. 3–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Henderson, R. W. Laing, and S. E. M. Langley, “Quality of life following treatment for early prostate cancer: Does Low Dose Rate (LDR) brachytherapy offer a better outcome? a review,” European Urology, vol. 45, no. 2, pp. 134–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. L. Potosky, W. W. Davis, R. M. Hoffman et al., “Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study,” Journal of the National Cancer Institute, vol. 96, no. 18, pp. 1358–1367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Rogers, M. Ohori, V. S. Kassabian, T. M. Wheeler, and P. T. Scardino, “Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels,” The Journal of Urology, vol. 153, no. 1, pp. 104–110, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Brenner and E. J. Hall, “Fractionation and protraction for radiotherapy of prostate carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 43, no. 5, pp. 1095–1101, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Hoskin, A. Rojas, P. Ostler et al., “High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity,” Radiotherapy and Oncology, vol. 110, no. 2, pp. 268–271, 2014. View at Publisher · View at Google Scholar · View at Scopus